Study Details
Eligibility requirements:
– Ages 18+
– Chronic atopic dermatitis/eczema that has been present for more than 1 year
– Not pregnant or nursing
– Not currently on any biologic therapies such as Dupixent® (dupilimab), Adbry™ (tralokinumab)
– Agree to not use any other treatment for atopic dermatitis/eczema (prescription or over-the-counter) during the study
About the study:
– This study is evaluating an investigational treatment for atopic dermatitis (eczema)
– Participants will receive $75.00 for each completed visit
– There are 5 study visits total over the course of 8 weeks
Map
Loading...
No Records Found
Sorry, no records were found. Please adjust your search criteria and try again.
Maps failed to load
Sorry, unable to load the Maps API.